Matthew is an associate editor for The American Journal of Managed Care® (AJMC®). He joined AJMC® in 2019 and creates content for Medical World News®, a 24-hour online program developed MJH Life Sciences® focusing on pressing topics within managed care, as well as the nonwork-related activities of health care stakeholders.
He has a BA in journalism & media studies and economics from Rutgers University. You can connect with Matthew on LinkedIn.
Lung Microbiome Found to Predict Outcomes in Critically Ill Patients
January 29th 2020Key features of the lung microbiome (bacterial burden, enrichment with gut-associated bacteria) were found to predict outcomes in critically ill patients, representing a potential therapeutic target for the prevention and treatment of acute respiratory failure, according to study findings.
Researchers Distinguish IL-24 as Pivotal Mediator of Pro-inflammatory, Allergic Skin Diseases
January 29th 2020Researchers exhibit recent advances in the basic characteristics of interleukin (IL)-24, a member of the IL-20 family of cytokines associated with pro-inflammatory autoimmune disorders such as psoriasis, arthritis, and inflammatory bowel diseases, as a catalyst in the pathogenesis of allergic skin inflammation.
Tolerance Complicates Sleep Benefit From Medical Cannabis Among Patients With Chronic Pain, Insomnia
January 29th 2020Medical cannabis was found to exhibit an overall positive effect on maintaining nightime sleep in patients with chronic pain, but frequent use was associated with problems of both waking up at night and falling asleep, according to study findings.
Researchers Uncover Differentially Expressed Genes Linked With Development, Progression of COPD
January 28th 2020In study findings demonstrating differentially expressed genes (DEGs) among healthy patients and those with chronic obstructive pulmonary disease (COPD), researchers show that key genes CYP1B1, VEGFA, BCL2, and CDKN1A may have significance in analyzing the development and progression of COPD.
ICER Releases Draft Evidence Report for Sickle Cell, Scoping Document for Hemophilia
January 25th 2020The Institute for Clinical and Economic Review (ICER) published a draft evidence report on crizanlizumab (Adakveo), voxelotor (Oxbryta), and L-glutamine (Endari) for sickle cell disease, as well as a draft scoping document on valoctocogene roxaparvovec, an investigational gene therapy, and emicizumab (Helimbra) for hemophilia.
Newly Approved Eye Drug Teprotumumab Shown to Reduce Swelling, Improve QoL
January 23rd 2020Teprotumumab, which was approved this week by the FDA, resulted in a greater frequency of proptosis reduction compared with placebo for patients with active thyroid eye disease, according to study results released Wednesday.
Review Suggests New Strategies of Managing Comorbid COPD, Hypertension
January 23rd 2020Researchers discuss optimal approaches to treating hypertension in patients with COPD, with a given patient’s underlying lung function and any coexisting conditions highlighted as important factors of drug therapy choice.
Jazz Pharmaceuticals Submits NDA for Therapy to Treat Excessive Daytime Sleepiness
January 23rd 2020Jazz Pharmaceuticals announced today it had redeemed its priority review voucher to submit a New Drug Application to the FDA on January 21, 2020; the company seeks approval for JZP-258, an investigational medication to treat cataplexy and excessive daytime sleepiness in patients 7 years and older with narcolepsy.
Managing Sickle Cell Disease: Innovations, Limitations Within Evolving Standards of Care
January 16th 2020In the evolving treatment landscape for sickle cell disease, current standards of treatment involve 4 drugs that have been FDA approved, with further innovations and limitations adding to the paradigm of care.
Blood Testing May Prove Effective Metric for Adolescent Sleep Duration, Study Shows
January 15th 2020Sleep duration was found to reflect the profile of specific circulating microRNAs in the blood of school-aged children and adolescents, indicating the potential efficacy of a blood test to examine those at risk of negative health outcomes related to insufficient sleep, according to study findings.
US Latino Population With Psoriasis Exposed to Heightened Disease Severity, Worse Quality of Life
January 9th 2020While prevalence rates of psoriasis are lower among the Latino population compared with the white and black populations in the United States, Latinos are shown to be disproportionately affected by poorer quality of life and intensified disease severity, according to study findings.
Overall US Cancer Mortality Rate Reaches 26-Year Decline, but Obesity-Related Cancer Deaths Rise
January 8th 2020The overall cancer death rate declined by 29% from 1991 to 2017, with a 2.2% decline from 2016 to 2017 serving as the largest single-year drop in reported cancer mortality, according to research published today; however, obesity-related cancer deaths are rising and prostate cancer deaths remain stagnant.
Cancer Treatments Exhibit Potential Therapeutic Efficacy Toward COPD, Study Shows
January 8th 2020Specific cancer drugs were shown to inhibit cell signaling processes that contribute to neutrophils, immune cells that cause inflammation to the lungs and serve as the main driver of lung damage in patients with chronic obstructive pulmonary disease (COPD), according to study findings.
Minimal, Extended Sleep Duration Linked to Development of Pulmonary Fibrosis
January 6th 2020People who regularly sleep less than 4 hours or more than 11 hours were found to be 2 to 3 times more likely to have pulmonary fibrosis compared with those who sleep for 7 hours a day, according to study results.
Nearly 8 in 10 Employers Express Concern About Financial Stability of Workers, Survey Shows
January 2nd 2020In MassMutual’s 2019 Workplace Financial Wellness Study, survey data gathered by Greenwald & Associates reported that a large majority of employers believe their employees are struggling financially in saving for retirement, settling debt, and dealing with medical costs.
Symptom Control of Parkinson Disease Linked to Ability, Productivity of Employment
December 15th 2019Study results presented at AMCP Nexus 2019 in National Harbor, Maryland, showed that 65.4% of patients with parkinson disease reported experiencing symptom recurrence, known as OFF periods, which impedes work productivity and employment.